Serial Number
78022510
Owner
ExonHit Therapeutics SAAttorney
Martin SavitzkyFiling Date
Aug 23, 2000
RESPONSE-HIT Trademark
Serial Number: 78022510 • Registration: 2669123
Trademark Classes
Class 5 - Pharmaceuticals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Class 9 - Computers & Electronics
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Class 10 - Medical Apparatus
Surgical, medical, dental and veterinary apparatus and instruments
Class 42 - Computer & Scientific
Scientific and technological services; industrial analysis and research services
Owner Contact Info
Legal Representation
Trademark Details
Filing Date
August 23, 2000
Registration Date
December 31, 2002
Published for Opposition
October 8, 2002
Cancellation Date
August 8, 2009
Goods & Services
Computer programs for medical testing, to analyze nucleic acids present in human or animal cells, using nucleic acid arrays on filters or chips and chemical reagents, to determine the effect of drugs on pathologies, namely, cancer and neurodegenerative diseases, and/or the characteristics of such pathologies, namely, cancer and neurodegenerative diseases
Nucleic acid arrays on filters or chips for use in medical research and medical tests permitting the analysis of nucleic acids present in human or animal cells to determine the effect of drugs on pathologies, namely, cancer and neurodegenerative diseases, and/or the characteristics of such pathologies, namely, cancer and neurodegenerative diseases; chemical reagents for medical use
Nucleic acid probes on filters or chips for use in medical research and medical tests permitting the analysis of nucleic acids present in human or animal cells to determine the effect of drugs on pathologies, namely, cancer and neurodegenerative diseases, and/or the characteristics of such pathologies, namely, cancer and neurodegenerative diseases
Medical testing services for analysis of nucleic acids found in human or animal cells to determine the presence of pathologies, namely, cancer and neurodegenerative diseases, or the effect of drugs on such pathologies, namely, cancer and neurodegenerative diseases
